Literature DB >> 16400290

Cognitive, affective, and behavioral side events in adults secondary to antiepileptic drug use.

Richard H Mattson1.   

Abstract

Antiepileptic drugs (AEDs) may contribute to and aggravate problems of cognition, mood, and behavior in some patients. The frequency and severity of the psychological disturbances are difficult to determine because many factors confound the interpretation of evidence whether it results from open case reports, controlled clinical trials, or neuropsychological testing. Concern about potential problems should not preclude trying an AED if other properties make the agent otherwise appropriate because the occurrence of adverse effects is often unpredictable in any given individual. Impairment can be minimized by gradual titration of dose and limiting total dose as clinically possible. If psychological problems arise and fine titration of the AED cannot eliminate the problem, the drug can be discontinued without permanent life threatening sequellae.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16400290

Source DB:  PubMed          Journal:  Rev Neurol Dis        ISSN: 1545-2913


  5 in total

Review 1.  Practical considerations for the treatment of elderly patients with migraine.

Authors:  Paola Sarchielli; Maria Luisa Mancini; Paolo Calabresi
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 2.  Negative effects of antiepileptic drugs on mood in patients with epilepsy.

Authors:  Marco Mula; Josemir W Sander
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

3.  Treatment of Medical Complications in Patients with Brain Tumors.

Authors:  Amy A Pruitt
Journal:  Curr Treat Options Neurol       Date:  2005-07       Impact factor: 3.972

4.  Medical management of patients with brain tumors.

Authors:  Amy A Pruitt
Journal:  Curr Treat Options Neurol       Date:  2011-08       Impact factor: 3.972

5.  Asenapine pharmacokinetics and tolerability in a pediatric population.

Authors:  Peter Dogterom; Robert Riesenberg; Rik de Greef; Justin Dennie; Martin Johnson; Venkatesh Pilla Reddy; André Mm Miltenburg; Robert L Findling; Abhijeet Jakate; Timothy J Carrothers; Matthew D Troyer
Journal:  Drug Des Devel Ther       Date:  2018-08-30       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.